CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENTS ANALYSIS
3.3.1. Patent analysis by year
3.3.2. Patent analysis by region
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS
3.5.1. DNA sequencing market share (2012-2017)
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities
CHAPTER 4 GLOBAL DNA SEQUENCING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. CONSUMABLES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.3. INSTRUMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
CHAPTER 5 GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. BIOMARKERS AND CANCER
5.2.1. Market size & forecast
5.3. DIAGNOSTICS
5.3.1. Market size & forecast
5.4. REPRODUCTIVE HEALTH
5.4.1. Market size & forecast
5.5. PERSONALIZED MEDICINE
5.5.1. Market size & forecast
5.6. FORENSICS
5.6.1. Market size & forecast
5.7. OTHER APPLICATIONS
5.7.1. Market size & forecast
CHAPTER 6 GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. SEQUENCING BY SYNTHESIS (SBS)
6.2.1. Market size & forecast
6.3. ION SEMICONDUCTOR SEQUENCING (IOS)
6.3.1. Market size & forecast
6.4. SEQUENCING BY LIGATION (SBL)
6.4.1. Market size & forecast
6.5. PYROSEQUENCING
6.5.1. Market size & forecast
6.6. SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
6.6.1. Market size & forecast
6.7. CHAIN TERMINATION SEQUENCING
6.7.1. Market size & forecast
6.8. NANOPORE SEQUENCING
6.8.1. Market size & forecast
CHAPTER 7 GLOBAL DNA SEQUENCING MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
7.2.1. Market size & forecast
7.3. PHARMACEUTICAL COMPANIES
7.3.1. Market size & forecast
7.4. BIOTECHNOLOGY COMPANIES
7.4.1. Market size & forecast
7.5. HOSPITALS & CLINICS
7.5.1. Market size & forecast
CHAPTER 8 GLOBAL DNA SEQUENCING MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size & forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. ILLUMINA, INC
9.1.1. Operating business segments
9.1.2. Business performance
9.2. THERMO FISHER SCIENTIFIC, INC
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. SIEMENS AG
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. ZS GENETICS, INC
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. AGILENT TECHNOLOGIES, INC
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ABBOTT LABORATORIES
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. BECKMAN COULTER
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. LI-COR
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments